109682 ⎘
dsDNA viruses; Details; Adenoviridae; Mastadenovirus, e.g. human or simian adenoviruses Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
COMBINATION TREATMENT REGIMES FOR TREATING CANCER
#2EGFR VACCINE CASSETTES
#3CTA VACCINE CASSETTES
#4RECOMBINANT VIRUS-LIKE PARTICLE CAPSID VACCINES AGAINST ADENOVIRUSES AND COMPOSITIONS, METHODS, AND USE THEREOF
#5STABILIZED FORMULATIONS OF CHIMPANZEE ADENOVIRUS
#6Novel chimpanzee adenovirus vector, construction method therefor, and application thereof
#7ADENOVIRAL VECTOR SYSTEM FOR GENE DELIVERY
#8COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION
#9METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#10NEOANTIGEN ADJUVANT AND MAINTENANCE THERAPY
#11USE OF ONCOLYTIC ADENOVIRUS FOR THE TREATMENT OF PEDIATRIC BRAIN CANCER
#12MODIFIED CHIMERIC CORONAVIRUS SPIKE PROTEIN FOR ENHANCEMENT OF VIRAL TITERS
#13ZIKA/DENGUE VACCINE AND APPLICATION THEREOF
#14Simian adenoviral vectors with two expression cassettes
#15METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#16ADENOVIRUS COMPRISING AN ALBUMIN-BINDING MOIETY
#17METHOD FOR PREPARING ADENOVIRUS VECTOR VACCINE BY MEANS OF PERFUSION CULTURE PROCESS
#18RAPID VERIFICATION OF VIRUS PARTICLE PRODUCTION FOR A PERSONALIZED VACCINE
#19Methods of vaccine administration
#20Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#21MULTIVIRUS-SPECIFIC T CELL IMMUNOTHERAPY
#22SHARED NEOANTIGEN VACCINES
#23DETARGETED ADENOVIRUS VARIANTS AND RELATED METHODS
#24VIRUSES WITH MODIFIED CAPSID PROTEINS
#25Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#26Adenoviral vector system for gene delivery
#27Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#28Compositions and methods for viral sensitization
#29Adenoviral coat protein derived delivery vehicles
#30PV-DELETED BOVINE ADENOVIRUS
#31IMMUNOGENIC PEPTIDES FOR USE IN THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES, IMMUNE RESPONSES TO ALLOFACTORS, ALLERGIC DISEASES, TUMORS, GRAFT REJECTION AND IMMUNE RESPONSES AGAINST VIRAL VECTORS USED FOR GENE THERAPY OR GENE VACCINATION
#32Triple live vaccine of canine distemper virus, canine parvovirus and canine infectious hepatitis virus
#33Multimerizing Polypeptides Derived From Jelly Roll Fold Domain of Adenovirus Penton Base
#34MULTIVIRUS-SPECIFIC T CELL IMMUNOTHERAPY
#35Simian adenovirus vectors comprising the ChAd-157 fiber protein
#36Adenovirus and uses thereof
#37Enhanced promoter
#38Rapid verification of virus particle production for a personalized vaccine
#39Stable, spray dried, immunogenic, viral compositions
#40Compositions and methods for viral sensitization
#41Adenoviral coat protein derived delivery vehicles
#42Adenovirus and uses thereof
#43Methods of vaccine administration
#44SIMIAN ADENOVIRAL VECTORS WITH TWO EXPRESSION CASSETTES
#45Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#46Hexon protein hypervariable region gene sequence of adenovirus and its application
#47Adenovirus comprising an albumin-binding moiety
#48Recombinant simian adenoviral vectors encoding a heterologous fiber protein and uses thereof
#49Immunization agents and methods of use
#50NOVEL RECOMBINANT ADENO-ASSOCIATED VIRUS CAPSIDS WITH ENHANCED HUMAN SKELETAL MUSCLE TROPISM
#51Detargeted adenovirus variants and related methods
#52Stable, spray dried, immunogenic, viral compositions
#53PV-DELETED BOVINE ADENOVIRUS
#54Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#55Potent and balanced bidirectional promoter
#56Hexon protein hypervariable region gene sequence of adenovirus and its application
#57COMPOSITIONS AND METHODS FOR TUMOR VACCINATION USING PROSTATE CANCER-ASSOCIATED ANTIGENS
#58Adenovirus based malaria vaccine encoding and displaying a malaria antigen
#59Adoptive T cell therapy
#60Enhanced thermal stability for adenoviral vectors through spray drying
#61METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT
#62Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
#63Human type 55 replication defective adenovirus vector, method for preparing same and uses thereof
#64Stable, Spray Dryed, Immunogenic, Viral Compositions
#65Compositions and methods for viral sensitization
#66Detargeted adenovirus variants and related methods
#67Chimpanzee clade E adenovirus nucleic acid-and amino acid-sequences, vectors containing same, and uses thereof
#68Stable, Spray Dryed, Immunogenic, Viral Compositions
#69Immunization agents and methods of use
#70Poxviral vaccines
#71Sequence arrangements and sequences for neoepitope presentation
#72Affenadenovirus (gorilla) or adenoviral vectors and methods of use
#73Treatment and prevention of malaria
#74Method and compositions
#75Recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
#76HPV vaccines and methods of use thereof
#77Breast cancer vaccines and methods of use thereof
#78Adenovirus comprising an albumin-binding moiety
#79Excipients for stabilising viral particles, polypeptides or biological material
#80Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#81Adenovirus isolated from titi monkeys
#82Dry formulations of vaccines that are room temperature stable
#83Subfamily E simian adenoviruses A1302, A1320, A1331 and A1337 and uses thereof
#84Adenovirus vectors
#85Methods of vaccine administration
#86METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT
#87Compositions for canine respiratory disease complex
#88Compositions and methods for the treatment or prevention of human adenovirus-36 infection
#89Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination
#90Sequential administration of a replication defective adenovirus vector in vaccination protocols
#91Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof
#92FORMULATIONS USEFUL FOR SPRAY DRYING VACCINES
#93Cancer therapy
#94COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONS
#95Stable, spray dryed, immunogenic, viral compositions
#96Adenovirus vectors
#97Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
#98Subunits of the adenovirus fiber protein and uses thereof as vaccines
#99VACCINE DIRECTED AGAINST ADENOVIRUS SEROTYPE 14
#100NOVEL VACCINE FOR DOG
#101Stabilizers for freeze-dried vaccines
#102Sequential administration of a replication defective adenovirus vector in vaccination protocols
#103METHODS OF VACCINE ADMINISTRATION
#104CYTOTOXIC T-CELL EPITOPE PEPTIDE AND USE THEREOF
#105Compositions Comprising a Recombinant Adenovirus and an Adjuvant
#106Compositions comprising viruses and methods for concentrating virus preparations
#107Raccoon poxvirus expressing rabies glycoproteins
#108COMPOSITIONS COMPRISING VIRUSES AND METHODS FOR CONCENTRATING VIRUS PREPARATIONS
#109Compositions comprising viruses and methods for concentrating virus preparations
#110CANINE VACCINES
#111Compositions Comprising Viruses and Methods for Concentrating Virus Preparations
#112Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes
#113Compositions comprising viruses and methods for concentrating virus preparations
#114Subunits of the adenovirus fiber protein and uses thereof as vaccines
#115Compositions comprising viruses and methods for concentrating virus preparations
#116Compositions comprising viruses and methods for concentrating virus preparations
#117Canine vaccines against Bordetella bronchiseptica